Live Breaking News & Updates on Halia Therapeutics

Stay updated with breaking news from Halia therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Halia Therapeutics Initiates Phase II Clinical Trial to Evaluate Efficacy of HT-6184, a First-in-Class NEK7/NLRP3 Inhibitor, on Post Procedural Inflammatory and Pain Responses

Halia Therapeutics Initiates Phase II Clinical Trial to Evaluate Efficacy of HT-6184, a First-in-Class NEK7/NLRP3 Inhibitor, on Post Procedural Inflammatory and Pain Responses
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

The Post , United States , Salt Lake City , Dave Bearss , Margitm Jan , Ignacio Guerrero Ros , Russo Partners , Company Contact , Halia Therapeutics Inc , Halia Therapeutics , Chief Medical Officer , Chief Executive Officer , Reduce Inflammation , Lake City , Post Procedural Inflammatory ,

BioUtah to Attend the J.P. Morgan 42nd Annual Healthcare Conference

BioUtah to Attend the J.P. Morgan 42nd Annual Healthcare Conference
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

United States , Denise Bell , Kelvyn Cullimore , Reportable Inc , Annual Healthcare Conference , Utah President , Annual Healthcare , Utah Kem , Policy Institute , Halia Therapeutics , Merit Medical Systems , Myriad Genetics , Thermo Fisher Scientific ,

First Patient Receives HT-6184 in Phase 2a Trial for Low-Risk MDS

A phase 2a trial administered the novel drug HT-6184 to its first patient with lower-risk myelodysplastic syndromes. ....

United States , American Cancer Society , Halia Therapeutics , Better First Line Therapy ,